To deter bioterrorism, U.S. imposes new rules on ordering synthetic DNA
Summary
The U.S. is tightening controls on ordering synthetic DNA to deter bioterrorism, with stricter screening, verification, and reporting requirements for suppliers and researchers. The piece discusses potential impacts on biotech labs, startups, and supply chains, and notes ongoing policy debates around biosafety and enforcement.